Dr. David P. Ellent
MD, Internal Medicine and Medical Oncology
Education:Fellowship – University of Texas M.D. Anderson Cancer Clinic Heavily involved in drug research and development.
Pblications:Cyclooxygenase-2 Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis (p 1096-1103) Jun-Yang Liou, David P. Ellent, Jennifer Goldsby,Bor-Sheng Ko, Nena Matijevic,Jaou-Chen Huang, Kenneth.K. Wu DOI: 10.1634/stemcells.2006-0505.Abstract Gemtuzumab ozogamicin (Mylotarg) Prior to Allogeneic Hematopoietic Stem Cell Transplantation Increases the Risk of Hepatic Veno-occlusive Disease: American Society of Hematology (poster presentation) Blood. Stuart Goldberg, MD;David Ellent, MD; Dmitry Shtrambrand, MD; May Abdo-Matkiwsky, DO; Stephanie Hamarman, MD; Jack W Hsu, MD; Scott D Rowely, MD; and Andrew L Pecora, MD. Autologous hematopoietic stem cell transplantation (HSCT) for the treatment of HIV-infected patients on HAART with non-Hodgkin’s lymphoma: D.P. Ellent, S.D. Rowely, S.L. Goldberg. A.L. Pecora, J.W. Hsu, D.S. Siegel; University of Medicine and Dentistry of New Jersey, Newark, NJ; Hackensack University Medical Center, Hackensack NJ Proc Am Soc Clin Oncol 22: page 600, 2003 (abstr 2414) (poster presentation) Professional Organizations: Texas Medical Association, Harris County Medical Society, MD Anderson Alumni Society, American Society of Clinical Oncology, American Medical Association. Hospital Privileges/ Affiliations: Memorial Hermann Northeast, Kingwood Medical Center, Memorial Hermann- The Woodlands, Memorial Hermann- Memorial City, Houston Northwest Medical Center, Huntsville Memorial Hospital, Conroe Regional Medical Center. Research and Presentations: City wide conferences within Houston Texas 2002 ASH Annual Meeting- poster presentation- Gemtuzumab ozogamicin (Mylotarg) Prior to Allogeneic Hematopoietic Stem Cell Transplantation increases the risk of Hepatic Veno-occlusive Disease,2003 ASCO Annual Meeting – poster presentation- Autologus hematopoietic stem cell transplantation (HSCT) for the treatment of HIV- infected patients on HAART with non-Hodgkin’s Lymphonam in HIV positive patients and extensive investigation of venoclusive disease after administration of Mylotarg Research investigation pathways of differentiation of stem cells.
- Medical Degree: Medical Doctorate, Ponce School of Medicine, Ponce, Puerto Rico, USA.
- Internship: Cabrini Medical Center, New York, NY.
- Residency: Internal Medicine, Cabrini Medical Center, New York, New York.
Chief Resident, Methodist Hospital, Brooklyn, New York.
- Mini-Residency: Stereotactic Radiosurgery, Intraoperative Radiation and Brachytherapy.
- Mini-Fellowship: Radiation Oncology, University of Texas Medical Branch Galveston, Texas Department Of Radiation Therapy.
- Board Certified: Board certified in radiation oncology by the American College of Radiology, board certified by the American College of Pain Management.
- Clinical Interests:
High Dose Rate (HDR) and Low Dose Rate (LDR) Brachytherapy, Stereotactic Radiosurgery, Breast, Gynecology, Head, Neck and Lung.